Cadre (NYSE:CDRE) Price Target Lowered to $37.00 at Roth Mkm

Cadre (NYSE:CDRE) had its price objective lowered by Roth Mkm from $39.00 to $37.00 in a research note released on Thursday,Benzinga reports. Roth Mkm currently has a buy rating on the stock.

Cadre Stock Performance

Shares of CDRE opened at $35.39 on Thursday. The company’s fifty day moving average is $36.90 and its 200-day moving average is $34.95. Cadre has a 12 month low of $29.18 and a 12 month high of $40.28. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 42.08, a price-to-earnings-growth ratio of 2.21 and a beta of 1.30. The company has a quick ratio of 2.14, a current ratio of 3.17 and a debt-to-equity ratio of 0.66.

Cadre (NYSE:CDRE) last posted its earnings results on Wednesday, November 6th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.03. The company had revenue of $109.41 million during the quarter, compared to analyst estimates of $126.27 million. Cadre had a return on equity of 13.44% and a net margin of 6.34%. The company’s revenue for the quarter was down 12.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.29 EPS. Equities analysts expect that Cadre will post 1.04 EPS for the current fiscal year.

Cadre Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, November 1st will be issued a $0.0875 dividend. The ex-dividend date is Friday, November 1st. This represents a $0.35 dividend on an annualized basis and a yield of 0.99%. Cadre’s dividend payout ratio (DPR) is presently 42.17%.

Institutional Trading of Cadre

Several hedge funds and other institutional investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD lifted its stake in Cadre by 32.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 460,500 shares of the company’s stock worth $16,671,000 after purchasing an additional 113,722 shares during the last quarter. Lisanti Capital Growth LLC lifted its stake in shares of Cadre by 127.5% in the first quarter. Lisanti Capital Growth LLC now owns 145,915 shares of the company’s stock worth $5,282,000 after buying an additional 81,780 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Cadre by 21.2% in the first quarter. Vanguard Group Inc. now owns 1,180,212 shares of the company’s stock worth $42,724,000 after purchasing an additional 206,564 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Cadre by 28.3% in the second quarter. Bank of New York Mellon Corp now owns 161,036 shares of the company’s stock worth $5,404,000 after purchasing an additional 35,476 shares during the last quarter. Finally, Old West Investment Management LLC increased its holdings in Cadre by 59.9% during the second quarter. Old West Investment Management LLC now owns 220,211 shares of the company’s stock valued at $7,390,000 after buying an additional 82,501 shares during the last quarter. Institutional investors own 43.95% of the company’s stock.

Cadre Company Profile

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.